热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
FITC anti-mouse NK-1.1 Antibody
产品名称：
FITC anti-mouse NK-1.1 Antibody
产品类别：
抗体
产品编号：
108705
产品应用：
108705
[价格]
规格 价格 库存
50µg ￥ 658 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
NK-1+ cells from mouse spleen and bone marrow
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation1,2, complement-dependent cytotoxicity3, in vivo depletion4,5,9,10, mediation of in vitro redirected lysis6, blocking of NK cell function7, induction of proliferation8, immunohistochemical staining of frozen sections11, immunofluorescence microscopy11, and spatial biology (IBEX)16,17. The LEAF? purified antibody (Endotoxin <0.1 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 108712).

Application References

(PubMed link indicates BioLegend citation)
  1. Carlyle JR, et al. 1999. J. Immunol. 162:5917. (IP)
  2. Sentman CL, et al. 1989. Hybridoma 8:605. (IP)
  3. Koo GC, et al. 1984. Hybridoma 3:301. (Cyt)
  4. Sentman CL, et al. 1989. J. Immunol. 142:1847. (Deplete)
  5. Koo GC, et al. 1986. J. Immunol. 137:3742. (Deplete)
  6. Karlhofer FM, et al. 1991. J. Immunol. 146:3662.
  7. Kung SK, et al. 1999. J. Immunol. 162:5876. (Block)
  8. Reichlin A, et al. 1998. Immunol. Cell Biol. 76:143.
  9. Drobyski W, et al. 1996. Blood 87:5355. (Deplete)
  10. Andoniou CE, et al. 2005. Nat. Immunol. 6:1011. (Deplete)
  11. Kanwar JR, et al. 2001. J. Natl. Cancer Inst. 93:1541. (IHC, IF)
  12. Kroemer A, et al. 2008. J. Immunol. 180:7818. PubMed
  13. Kim JY, et al. 2009. Exp Mol Med. 30:288. PubMed
  14. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  15. Lee H, et al. 2014. Invest Ophthalmol Vis Sci. 55:2885. PubMed
  16. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  17. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Zaman R, et al. 2021. Immunity. :. PubMed
  2. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  3. Gilleron J et al. 2018. Cell reports. 25(12):3329-3341 . PubMed
  4. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  5. Leier A, et al. 2022. Mol Ther Nucleic Acids. 28:261. PubMed
  6. Chung YM, et al. 2022. Am J Cancer Res. 12:1241. PubMed
  7. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  8. Molina-Sanchez P, et al. 2020. Gastroenterology. 2203:159. PubMed
  9. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  10. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  11. Lebratti T, et al. 2021. eLife. 10:00. PubMed
  12. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  13. Fullertona A, et al. 2013. Toxicol Appl Pharmacol. 266:317. PubMed
  14. Li X, et al. 2014. PLoS One. 9:108192. PubMed
  15. Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed
  16. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  17. Lissner MM, et al. 2020. Elife. 9:00. PubMed
  18. K?chl R, et al. 2020. Elife. 9:00. PubMed
  19. Song Y, et al. 2016. Mol Cancer Ther. 15: 2413 - 2421. PubMed
  20. Kotfis K, et al. 2020. British Journal of Pharmacology. 49(1):66-72. PubMed
  21. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  22. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  23. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  24. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  25. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  26. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  27. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  28. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  29. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  30. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  31. Pardy RD, et al. 2021. Nat Commun. 12:4051. PubMed
  32. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  33. Calcinotto A, et al. 2018. Nat Commun. 9:4832. PubMed
  34. Chung YM, et al. 2021. J Immunother Cancer. 9:. PubMed
  35. QT N, et al. 2015. Antimicrob Agents Chemother. 59: 6308-6316. PubMed
  36. Ballesteros I, et al. 2020. Cell. 183(5):1282-1297.e18. PubMed
  37. Wolf KG, et al. 2022. JVS Vasc Sci. 3:336. PubMed
  38. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  39. Giampazolias E, et al. 2021. Cell. . PubMed
  40. Robinett RA et al. 2018. Cell systems. 7(1):41-48 . PubMed
  41. Shahzad KA, et al. 2018. Drug Deliv. 25:703. PubMed
  42. Zhang W, et al. 2019. Mar Drugs. 0.845138889. PubMed
  43. Fu S, et al. 2020. Nat Commun. 0.7625. PubMed
  44. Bronisz–Budzynska I, et al. 2019. Skelet Muscle. 9:22. PubMed
  45. Ruscher R, et al. 2018. Bio Protoc. 8:e2757. PubMed
  46. Lam KC, et al. 2021. Cell. 184:5338. PubMed
  47. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  48. Valkenburg S, et al. 2016. Sci Rep. 6:22666. PubMed
  49. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  50. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  51. Nam J, et al. 2021. Adv Ther (Weinh). 4:. PubMed
  52. Schaffert S, et al. 2015. J Immunol. 195: 1470-1479. PubMed
  53. Jia H, et al. 2018. Int J Oncol. 53:949. PubMed
  54. Bárcena C et al. 2019. EBioMedicine. 43:513-524 . PubMed
  55. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  56. Werner A, et al. 2021. iScience. 24:103076. PubMed
  57. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  58. Iwanami N, et al. 2020. iScience. 23:101260. PubMed
  59. Chen J, et al. 2014. Cell Res. 24:1050. PubMed
  60. Wang X, et al. 2022. Elife. 11:. PubMed
  61. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  62. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  63. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  64. Sun D, et al. 2020. PLoS Pathog. 16:e1008361. PubMed
RRID
AB_313392 (BioLegend Cat. No. 108705) AB_313393 (BioLegend Cat. No. 108706)

Antigen Details

Structure
NKR-P1 gene family
Distribution

NK and NK-T cells in the NK1.1 mouse strains (C57BL, FVB/N, NZB)

Function
NK cell activation, IFN-γ production, cytotoxic granule release
Cell Type
NK cells, NKT cells
Biology Area
Immunology, Innate Immunity
Antigen References

1. Lanier LL. 1997. Immunity 6:371.
2. Yokoyama WM, et al. 1993. Ann. Rev. Immunol. 11:613.
3. Koo GC, et al. 1986. J. Immunol. 137:3742.
4. Giorda R, et al. 1991. J. Immunol. 147:1701.

Gene ID
17059 View all products for this Gene ID
UniProt
View information about NK-1.1 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线